Media Alert: IBM Applauds EU Parliament's Approval of the EU AI Act
Media Alert: IBM Applauds EU Parliament's Approval of the EU AI Act
PR Newswire
BRUSSELS, March 13, 2024
BRUSSELS, March 13, 2024 /PRNewswire/ -- IBM (NYSE: IBM) applauds the EU Parliament's decision to adopt the EU AI Act, a significant milestone in establishing responsible AI regulation in the European Union.
The EU AI Act provides a much-needed framework for ensuring transparency, accountability, and human oversight in developing and deploying AI technologies. While important work must be done to ensure the Act is successfully implemented, IBM believes the regulation will foster trust and confidence in AI systems while promoting innovation and competitiveness.
"I commend the EU for its leadership in passing comprehensive, smart AI legislation. The risk-based approach aligns with IBM's commitment to ethical AI practices and will contribute to building open and trustworthy AI ecosystems," said Christina Montgomery, Vice President and Chief Privacy & Trust Officer at IBM. "IBM stands ready to lend our technology and expertise – including our watsonx.governance product – to help our clients and other stakeholders comply with the EU AI Act and upcoming legislation worldwide so we can all unlock the incredible potential of responsible AI."
For more information, visit watsonx.governance and ibm.com/consulting/ai-governance.
Media Contact:
IBM
Ashley Bright
brighta@us.ibm.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/media-alert-ibm-applauds-eu-parliaments-approval-of-the-eu-ai-act-302088002.html
SOURCE IBM
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
5 Stocks to Buy That We Still Like After They’ve Run Up
-
Markets Brief: Stocks Are Starting to Look Cheap Again
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track
-
American Airlines Earnings: We See Costs Overshadowing Market Share This Year
-
Snap Earnings: Advertising Growth and Snapchat+ Drive Monetization
-
STMicro Earnings: We Still See an Attractive Margin of Safety Despite a Poor First-Half Forecast
-
Alphabet Shares Surge on Strong Earnings, Dividend Surprise
-
Microsoft Earnings: Firm Beats Forecasts on Strong AI and Cloud Demand
-
PG&E Earnings: Near-Term Regulatory Certainty Supports Industry-Leading Earnings Growth